Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor, with rising incidence and mortality rates posing a significant threat to global public health. Accurate prediction of liver cancer occurrence and progression is essential for improving patient prognosis. This study uses bibliometric methods to analyze the current state and future trends in liver cancer pre...
Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. Prophylactic cancer vaccines have prevented several malignancies by protecting against cancer-causing pathogens. By contrast, therapeutic vaccines training the immune system to eliminate established tumours are now showing real promise in clinical settings. In the adjuva...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, yet the response rate remains limited, with only about 30% of solid tumor pa...
The treatment of choice for canine alimentary tract neoplasms is surgical excision, but it can sometimes be difficult to achieve wide margins due to n...
Immune dysregulation and metabolism reprogramming are implicated in bladder cancer (BLCA), the relationships between immunometabolism (IMB) and BLCA r...
BACKGROUND: Distant metastasis (DM) in intrahepatic cholangiocarcinoma (ICC) is associated with poor prognosis and significantly high mortality. There...
Deep learning (DL) models have shown promise in predicting axillary lymph node (ALN) status. However, most existing DL models were classification-only...
Brain tumor classification using Magnetic Resonance Imaging (MRI) images is an important and emerging field of medical imaging and artificial intellig...
Visualizing the chemical compositions of biological samples is pivotal to advancing biological sciences, with the past two decades witnessing the emer...
Radiotherapy resistance in nasopharyngeal carcinoma (NPC) is a major cause of recurrence and metastasis. Identifying radiotherapy-related biomarkers i...
The recent introduction of the term non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) marked a pivotal shift in th...
BACKGROUND: Nasopharyngeal carcinoma (NPC) exhibits unique histopathological characteristics compared to other head and neck cancers. The prognosis of...
Hypoxia arises in most solid tumors with insufficient blood flow, which hinders the delivery and efficacy of therapeutic agents to tumors. In this wor...
Intravesical drug instillation is a common treatment for bladder cancer, but it suffers from poor targeting and suboptimal patient experience due to t...
Engineered lipid nanoparticles (LNPs) represent a breakthrough in targeted drug delivery, enabling precise spatiotemporal control essential to treat c...
Current lung cancer diagnostic techniques primarily focus on tissue subtype classification, yet remain inadequate in distinguishing pathological progr...
Monitoring cancer therapy is difficult because of restricted imaging depth, inadequate molecular specificity, and delayed response evaluation. Moreove...
BACKGROUND: Primary liver cancer is the sixth most common cancer globally and ranks third in cancer-related mortality. Patients with distant metastasi...
OBJECTIVE: WHO grade 4 glioma is the most common primary malignant brain tumor, with a median survival of only 14.6 months. Predicting survival outcom...
PURPOSE: The non-invasive assessment of central lymph node metastasis (CLNM) in patients with papillary thyroid carcinoma (PTC) plays a crucial role i...